Skin Health LBO sees second lien success

The largest second lien tranche since the financial crisis, a Sfr1.3bn-equivalent deal, was placed to just five accounts, GlobalCapital understands, supporting EQT, Luxina and PSP’s $10bn buyout of Nestlé Skin Health. The big second lien tickets illustrate the depth of demand for the product, which has been buoyed by the cash raised for direct lending opportunities — and supports the deal through senior syndication.

  • By Owen Sanderson
  • 04 Jul 2019

Deutsche Bank and Credit Suisse, left leads on the euro and dollar tranches respectively, launched the senior debt backing the buyout into general syndication this week, with lender meetings on Monday and Tuesday in London and New York.

This followed weeks of premarketing, which saw certain ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

Bookrunners of European Leveraged Loans

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 5,589.28 27 6.64%
2 Goldman Sachs 5,310.66 28 6.31%
3 Credit Agricole CIB 4,996.05 29 5.93%
4 BNP Paribas 4,989.41 40 5.93%
5 Deutsche Bank 4,671.96 29 5.55%

Bookrunners of European HY Bonds

Rank Lead Manager Amount €m No of issues Share %
  • Last updated
  • Today
1 Deutsche Bank 2,970.40 18 7.46%
2 JPMorgan 2,822.43 22 7.09%
3 Citi 2,783.23 20 6.99%
4 BNP Paribas 2,674.33 25 6.72%
5 Goldman Sachs 2,523.29 20 6.34%

Bookrunners of Dollar Denominated HY Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 16,336.99 132 10.01%
2 Citi 14,953.44 126 9.16%
3 Bank of America Merrill Lynch 12,173.13 103 7.46%
4 Goldman Sachs 12,028.93 93 7.37%
5 Morgan Stanley 9,577.47 74 5.87%